Chapter 17. Advances in Immune Monitoring Strategies for Cancer Vaccines and Immunotherapy

  1. Rimas Orentas PhD2,
  2. James W. Hodge PhD3 and
  3. Bryon D. Johnson PhD4
  1. Seunghee Kim-Schulze PhD,
  2. Moshe Ornstein BS and
  3. Howard L. Kaufman MD Director

Published Online: 1 MAR 2007

DOI: 10.1002/9780470170113.ch17

Cancer Vaccines and Tumor Immunity

Cancer Vaccines and Tumor Immunity

How to Cite

Kim-Schulze, S., Ornstein, M. and Kaufman, H. L. (2008) Advances in Immune Monitoring Strategies for Cancer Vaccines and Immunotherapy, in Cancer Vaccines and Tumor Immunity (eds R. Orentas, J. W. Hodge and B. D. Johnson), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470170113.ch17

Editor Information

  1. 2

    Departments of Pediatrics, Medicine, Microbiology and Molecular Genetics, Medical College of Wisconsin and the Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI, USA

  2. 3

    Department of Medical Biology, University of Tennessee Medical Center and Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

  3. 4

    Department of Pediatrics, Medical College of Wisconsin and the Children's Research Institute, Children's Hospital of Wisconsin., Milwaukee, WI, USA

Author Information

  1. The Tumor Immunology Laboratory, Division of Surgical Oncology, Columbia University Medical Center, New York, NY, USA

Publication History

  1. Published Online: 1 MAR 2007
  2. Published Print: 22 JAN 2008

ISBN Information

Print ISBN: 9780470074749

Online ISBN: 9780470170113

SEARCH

Keywords:

  • immune monitoring - cancer vaccine and immunotherapy;
  • enzyme-linked immunospot assay (ELISpot);
  • T cell proliferation assay

Summary

This chapter contains sections titled:

  • Introduction

  • Current Status of Tumor Immunotherapy

  • Assay Validation

  • Conclusions

  • References